Nimesulid Slavia (Nimesulide)

Nimesulide acts on inflammatory pathways to provide analgesic and antipyretic effects.

• Mild to moderate pain: reduces pain intensity by inhibiting prostaglandin synthesis at sites of nociception.
• Inflammatory conditions: diminishes swelling and redness associated with acute inflammation.
• Osteoarthritis: alleviates joint pain and improves mobility in degenerative joint disease.
• Dysmenorrhea: lessens menstrual cramps and associated discomfort.
• Fever: lowers elevated body temperature through central antipyretic action.

• Nimesulide selectively inhibits the cyclooxygenase‑2 (COX‑2) enzyme, decreasing the conversion of arachidonic acid to prostaglandins that mediate pain, inflammation and fever. By sparing COX‑1 activity, it aims to reduce gastrointestinal toxicity while maintaining anti‑inflammatory efficacy. The reduced prostaglandin levels lead to diminished sensitization of nociceptors and lower hypothalamic temperature set‑point. Consequently, the drug provides analgesic relief and antipyretic action without markedly affecting platelet aggregation.

Nimesulide may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Gastrointestinal discomfort
• Nausea
• Headache
• Dizziness

Serious or Rare Side Effects

• Hepatotoxicity, including elevated liver enzymes
• Severe skin reactions such as Stevens‑Johnson syndrome
• Gastrointestinal ulceration or bleeding
• Renal impairment or failure

Before prescribing Nimesulide, clinicians should consider several precautionary measures to minimize risk.

• Assess liver function before initiating: obtain baseline hepatic enzymes and monitor periodically.
• Avoid in patients with known hypersensitivity to NSAIDs: discontinue immediately if allergic reaction occurs.
• Use the lowest effective dose for the shortest duration: limit exposure to reduce adverse events.
• Monitor for gastrointestinal symptoms: consider gastroprotective agents in high‑risk individuals.
• Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture.

Nimesulide can interact with other medicines, altering its safety or effectiveness.

Major Interactions (Avoid)

• Concurrent use with other COX‑2 inhibitors: increased risk of toxicity and organ damage.
• Combination with anticoagulants (e.g., warfarin, heparin): heightened bleeding risk.
• Concurrent use with hepatotoxic drugs (e.g., isoniazid, methotrexate): potential liver injury.

Moderate Interactions (Monitor Closely)

• Use with diuretics or ACE inhibitors: may affect renal function and electrolyte balance.
• Combination with corticosteroids: increased risk of gastrointestinal ulceration.
• Concurrent use with lithium: may raise lithium serum levels, requiring monitoring.